TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ADCT

ADC Therapeutics SA

Healthcare · Biotechnology

1.30$ -1.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ADCT
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
-1.27 -2.25 -1.82 -2.58 -3.04 -1.75 -1.45 -1.27 -1.11
0.01 0.01 0.02 0.03 0.03 0.03 0.04 0.03 0.01
0.02 0.01 0.02 0.57 0.79 0.63 0.17 0.07 0.05
0.02 0.00 0.01 0.97 0.19 0.64 – – –
0.23 0.01 -0.12 0.19 -0.20 -0.42 0.54 0.04 -0.20
0.05 0.05 0.03 0.04 0.08 0.01 0.04 0.01 0.00
-0.06 -0.05 -0.03 -0.04 -0.09 -0.03 -0.04 -0.01 0.00
3.35 0.00 0.00 0.00 0.00 0.00 – – –
-0.02 -0.02 -0.01 0.94 0.63 -0.08 0.00 – –
3.35 0.00 1.50 7.57 3.48 -0.01 0.90 1.00 1.19
2.02 -2.30 -0.35 4.95 0.36 -1.79 -0.59 -0.29 0.08
-1.33 -2.30 -1.85 -2.62 -3.12 -1.76 -1.49 -1.28 -1.11

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?